203 related articles for article (PubMed ID: 29673856)
1. 2,3,7,8-Tetrachlorodibenzo-p-dioxin dose-dependently increases bone mass and decreases marrow adiposity in juvenile mice.
Fader KA; Nault R; Raehtz S; McCabe LR; Zacharewski TR
Toxicol Appl Pharmacol; 2018 Jun; 348():85-98. PubMed ID: 29673856
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of tributyltin and 2,3,7,8-tetrachlorodibenzo-p-dioxin on differentiating osteoblasts and osteoclasts.
Koskela A; Viluksela M; Keinänen M; Tuukkanen J; Korkalainen M
Toxicol Appl Pharmacol; 2012 Sep; 263(2):210-7. PubMed ID: 22749964
[TBL] [Abstract][Full Text] [Related]
3. Induction of a chloracne phenotype in an epidermal equivalent model by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on aryl hydrocarbon receptor activation and is not reproduced by aryl hydrocarbon receptor knock down.
Forrester AR; Elias MS; Woodward EL; Graham M; Williams FM; Reynolds NJ
J Dermatol Sci; 2014 Jan; 73(1):10-22. PubMed ID: 24161567
[TBL] [Abstract][Full Text] [Related]
4. Evidence for Aryl hydrocarbon Receptor-Mediated Inhibition of Osteoblast Differentiation in Human Mesenchymal Stem Cells.
Watson ATD; Nordberg RC; Loboa EG; Kullman SW
Toxicol Sci; 2019 Jan; 167(1):145-156. PubMed ID: 30203000
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice with a constitutively active aryl hydrocarbon receptor display a gender-specific bone phenotype.
Wejheden C; Brunnberg S; Larsson S; Lind PM; Andersson G; Hanberg A
Toxicol Sci; 2010 Mar; 114(1):48-58. PubMed ID: 19934163
[TBL] [Abstract][Full Text] [Related]
6. CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption.
Motyl KJ; Raetz M; Tekalur SA; Schwartz RC; McCabe LR
Am J Physiol Regul Integr Comp Physiol; 2011 May; 300(5):R1250-60. PubMed ID: 21346244
[TBL] [Abstract][Full Text] [Related]
7. New insights to the role of aryl hydrocarbon receptor in bone phenotype and in dioxin-induced modulation of bone microarchitecture and material properties.
Herlin M; Finnilä MA; Zioupos P; Aula A; Risteli J; Miettinen HM; Jämsä T; Tuukkanen J; Korkalainen M; Håkansson H; Viluksela M
Toxicol Appl Pharmacol; 2013 Nov; 273(1):219-26. PubMed ID: 24035824
[TBL] [Abstract][Full Text] [Related]
8. Dioxin-induced up-regulation of the active form of vitamin D is the main cause for its inhibitory action on osteoblast activities, leading to developmental bone toxicity.
Nishimura N; Nishimura H; Ito T; Miyata C; Izumi K; Fujimaki H; Matsumura F
Toxicol Appl Pharmacol; 2009 May; 236(3):301-9. PubMed ID: 19367694
[TBL] [Abstract][Full Text] [Related]
9. Developmental exposure to 2,3,7,8 tetrachlorodibenzo-p-dioxin attenuates capacity of hematopoietic stem cells to undergo lymphocyte differentiation.
Ahrenhoerster LS; Tate ER; Lakatos PA; Wang X; Laiosa MD
Toxicol Appl Pharmacol; 2014 Jun; 277(2):172-82. PubMed ID: 24709672
[TBL] [Abstract][Full Text] [Related]
10. Dioxin-induced retardation of development through a reduction in the expression of pituitary hormones and possible involvement of an aryl hydrocarbon receptor in this defect: a comparative study using two strains of mice with different sensitivities to dioxin.
Takeda T; Taura J; Hattori Y; Ishii Y; Yamada H
Toxicol Appl Pharmacol; 2014 Aug; 278(3):220-9. PubMed ID: 24793433
[TBL] [Abstract][Full Text] [Related]
11. Nicotine affects bone resorption and suppresses the expression of cathepsin K, MMP-9 and vacuolar-type H(+)-ATPase d2 and actin organization in osteoclasts.
Tanaka H; Tanabe N; Kawato T; Nakai K; Kariya T; Matsumoto S; Zhao N; Motohashi M; Maeno M
PLoS One; 2013; 8(3):e59402. PubMed ID: 23555029
[TBL] [Abstract][Full Text] [Related]
12. Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity.
Fader KA; Nault R; Kirby MP; Markous G; Matthews J; Zacharewski TR
Toxicol Appl Pharmacol; 2017 Apr; 321():1-17. PubMed ID: 28213091
[TBL] [Abstract][Full Text] [Related]
13. Aryl Hydrocarbon Receptor (AhR) Activation by 2,3,7,8-Tetrachlorodibenzo-
Fling RR; Zacharewski TR
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830313
[TBL] [Abstract][Full Text] [Related]
14. Role of aryl hydrocarbon receptor (AHR) in overall retinoid metabolism: Response comparisons to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure between wild-type and AHR knockout mice.
Esteban J; Sánchez-Pérez I; Hamscher G; Miettinen HM; Korkalainen M; Viluksela M; Pohjanvirta R; Håkansson H
Reprod Toxicol; 2021 Apr; 101():33-49. PubMed ID: 33607186
[TBL] [Abstract][Full Text] [Related]
15. Prevention of bone growth defects, increased bone resorption and marrow adiposity with folinic acid in rats receiving long-term methotrexate.
Fan CM; Foster BK; Hui SK; Xian CJ
PLoS One; 2012; 7(10):e46915. PubMed ID: 23071661
[TBL] [Abstract][Full Text] [Related]
16. Bone resorption by aryl hydrocarbon receptor-expressing osteoclasts is not disturbed by TCDD in short-term cultures.
Ilvesaro J; Pohjanvirta R; Tuomisto J; Viluksela M; Tuukkanen J
Life Sci; 2005 Aug; 77(12):1351-66. PubMed ID: 15913656
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor expression and activity in cerebellar granule neuroblasts: implications for development and dioxin neurotoxicity.
Williamson MA; Gasiewicz TA; Opanashuk LA
Toxicol Sci; 2005 Feb; 83(2):340-8. PubMed ID: 15537747
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor (Fgf) 21 is a novel target gene of the aryl hydrocarbon receptor (AhR).
Cheng X; Vispute SG; Liu J; Cheng C; Kharitonenkov A; Klaassen CD
Toxicol Appl Pharmacol; 2014 Jul; 278(1):65-71. PubMed ID: 24769090
[TBL] [Abstract][Full Text] [Related]
19. Dioxins interfere with differentiation of osteoblasts and osteoclasts.
Korkalainen M; Kallio E; Olkku A; Nelo K; Ilvesaro J; Tuukkanen J; Mahonen A; Viluksela M
Bone; 2009 Jun; 44(6):1134-42. PubMed ID: 19264158
[TBL] [Abstract][Full Text] [Related]
20. From the Cover: High Susceptibility of Lrig1 Sebaceous Stem Cells to TCDD in Mice.
Fontao F; Barnes L; Kaya G; Saurat JH; Sorg O
Toxicol Sci; 2017 Dec; 160(2):230-243. PubMed ID: 28973660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
